CompletedNot Applicable

Predictors and Long-term Incidence of In-stent Restenosis After Chronic Total Occlusion Percutaneous Coronary Intervention

Finland294 participantsStarted 2023-01-16

Plain-language summary

The goal of this clinical trial is to describe the long-term (≥ 3 years) patency of coronary artery stents following chronic total occlusion percutaneous coronary intervention (CTO PCI). The main questions it aims to answer are: * What is the incidence of in-stent restenosis after CTO PCI? * What are patient-, lesion-, and procedure-related factors associated with an increased risk of in-stent restenosis after CTO PCI?

Who can participate

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Exclusion criteria

✕. ISR or an inconclusive finding within the CTO stent.
✕. Anginal symptoms with either ≥ 50 % stenosis or an inconclusive finding in any native coronary artery or within a non-CTO stent.

What they're measuring

Cumulative incidence of long-term ISR after CTO PCI

Timeframe: Through study completion, up to 10.9 years, with an average follow-up of 7.1 years.

Trial details

NCT IDNCT07473596

SponsorLauri Mansikkaniemi

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-02-06

View on ClinicalTrials.gov More Coronary Artery Disease (CAD) trials